Araştırma Makalesi

Flow cytometric evaluation and outcomes of pediatric acute leukemia patients

Cilt: 46 Sayı: 1 31 Mart 2021
PDF İndir
TR EN

Flow cytometric evaluation and outcomes of pediatric acute leukemia patients

Öz

Purpose: In this study, the outcomes and flow cytometry results of childhood acute leukemia patients and their relationship with the prognosis and other clinical conditions was investigated. Materials and Methods: A total of 93 patients, including 69 acute lymphoblastic leukemia (ALL) and 24 acute myeloid leukemia (AML) patients diagnosed at our hospital between January 2008 and November 2013, were included. Results: 5-year overall survival (OS) was 66% in ALL patients and 80% in AML patients. When leukemia patients were classified flow cytometrically according to their cell surface antigens (CD); 5-year OS was 77% in CD2(+) patients and 58% in CD2(-) patients. Five-year OS was 82% in patients with CD10(+) and 61% in patients with CD10(-). However, the results were not statistically significant (p>0.05). ALL patients were divided into two groups as ALL with positive T cell markers and ALL with positive B cell markers in the foreground and evaluated accordingly, and the OS of ALL patients with positive T cell markers in the foreground was lower than ALL patients with positive B cell markers in the 5 year (59% and 75%, respectively) (p =0.518). On the other hand, AML patients were divided into two groups as AML with positive lymphoid markers and AML with negative lymphoid markers, and the 5 year OS of AML patients with positive lymphoid markers was higher than AML patients with negative lymphoid markers (83% and 70%, respectively) (p = 0.638). These results were not statistically significant. Conclusion: In the flow cytometric evaluation of our patients with leukemia, it was found that patients with CD10(+) had a better 5-year OS and patients with CD2(+) had a lower 5-year OS. The results of patients with positive B cell markers were better in ALL patients, and the results of patients with positive lymphoid markers were better in AML patients.

Anahtar Kelimeler

acute leukemia, flow cytometry, prognosis

Kaynakça

  1. References1. McKenney AH, Cleary ML, Arber DA. Pathology and Molecular Diagnosis of Leukemias and Lymphomas. In: Pizzo PA, Poplack DG, Eds. Principles and Practice of Pediatric Oncology, 7th ed. Philadelphia: Wolters Kluwer. 2016;113-30.
  2. References2. Rabin KR, Gramatges MM, Margolin JF, Poplack DG. Acute Lymphoblastic Leukemia. In Pizzo PA, Poplack DG, Eds. Principles and Practice of Pediatric Oncology, 7th ed. Philadelphia: Wolters Kluwer. 2016;463-97.
  3. References3. Arceci RJ, Meshinchi S. Acute Myeloid Leukemia and Myelodysplastic Syndromes. In: Pizzo PA and Poplack DG, Eds. Principles and Practice of Pediatric Oncology, 7th ed. Philadelphia: Wolters Kluwer. 2016;498-544.

Kaynak Göster

APA
Genç, B., Özkan, A., Bayram, İ., Sezgin, G., Küpeli, S., & Tanyel,i, A. (2021). Flow cytometric evaluation and outcomes of pediatric acute leukemia patients. Cukurova Medical Journal, 46(1), 149-159. https://izlik.org/JA63HH55NS
AMA
1.Genç B, Özkan A, Bayram İ, Sezgin G, Küpeli S, Tanyel,i A. Flow cytometric evaluation and outcomes of pediatric acute leukemia patients. Cukurova Med J. 2021;46(1):149-159. https://izlik.org/JA63HH55NS
Chicago
Genç, Burcu, Ayşe Özkan, İbrahim Bayram, Gülay Sezgin, Serhan Küpeli, ve Atila Tanyel,i. 2021. “Flow cytometric evaluation and outcomes of pediatric acute leukemia patients”. Cukurova Medical Journal 46 (1): 149-59. https://izlik.org/JA63HH55NS.
EndNote
Genç B, Özkan A, Bayram İ, Sezgin G, Küpeli S, Tanyel,i A (01 Mart 2021) Flow cytometric evaluation and outcomes of pediatric acute leukemia patients. Cukurova Medical Journal 46 1 149–159.
IEEE
[1]B. Genç, A. Özkan, İ. Bayram, G. Sezgin, S. Küpeli, ve A. Tanyel,i, “Flow cytometric evaluation and outcomes of pediatric acute leukemia patients”, Cukurova Med J, c. 46, sy 1, ss. 149–159, Mar. 2021, [çevrimiçi]. Erişim adresi: https://izlik.org/JA63HH55NS
ISNAD
Genç, Burcu - Özkan, Ayşe - Bayram, İbrahim - Sezgin, Gülay - Küpeli, Serhan - Tanyel,i, Atila. “Flow cytometric evaluation and outcomes of pediatric acute leukemia patients”. Cukurova Medical Journal 46/1 (01 Mart 2021): 149-159. https://izlik.org/JA63HH55NS.
JAMA
1.Genç B, Özkan A, Bayram İ, Sezgin G, Küpeli S, Tanyel,i A. Flow cytometric evaluation and outcomes of pediatric acute leukemia patients. Cukurova Med J. 2021;46:149–159.
MLA
Genç, Burcu, vd. “Flow cytometric evaluation and outcomes of pediatric acute leukemia patients”. Cukurova Medical Journal, c. 46, sy 1, Mart 2021, ss. 149-5, https://izlik.org/JA63HH55NS.
Vancouver
1.Burcu Genç, Ayşe Özkan, İbrahim Bayram, Gülay Sezgin, Serhan Küpeli, Atila Tanyel,i. Flow cytometric evaluation and outcomes of pediatric acute leukemia patients. Cukurova Med J [Internet]. 01 Mart 2021;46(1):149-5. Erişim adresi: https://izlik.org/JA63HH55NS